BAKER BROS. ADVISORS LP Q2 2021 Filing
Filed August 16, 2021
Portfolio Value
$22.8T
Holdings
120
Report Date
Q2 2021
Filing Type
13F-HR
All Holdings (120 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | SGENUSDSeagen Inc. | 47,288,259 | $7.5T | 32.79% | |
| 2 | ONCBeiGene, Ltd. | 11,668,897 | $4.0T | 17.59% | |
| 3 | INCYIncyte Corporation | 32,021,732 | $2.7T | 11.83% | |
| 4 | KODKodiak Sciences Inc. | 14,137,881 | $1.3T | 5.77% | |
| 5 | ACADACADIA Pharmaceuticals Inc. | 41,910,704 | $1.0T | 4.49% | |
| 6 | BMRNBioMarin Pharmaceutical Inc. | 7,589,294 | $633.3B | 2.78% | |
| 7 | ASNDAscendis Pharma A/S | 3,540,270 | $465.7B | 2.05% | |
| 8 | NVTA1EURInvitae Corporation | 10,248,575 | $345.7B | 1.52% | |
| 9 | ARGXargenx SE | 1,119,557 | $337.1B | 1.48% | |
| 10 | PRLDPrelude Therapeutics Incorporated | 10,123,824 | $289.8B | 1.27% | |
| 11 | 1K0IGM Biosciences, Inc. | 3,156,102 | $262.6B | 1.15% | |
| 12 | ABCLAbCellera Biologics Inc. | 10,450,180 | $229.9B | 1.01% | |
| 13 | MRTXEURMirati Therapeutics, Inc. | 1,409,784 | $227.7B | 1.00% | |
| 14 | BCRXBioCryst Pharmaceuticals, Inc. | 12,710,818 | $201.0B | 0.88% | |
| 15 | MDGLMadrigal Pharmaceuticals, Inc. | 1,499,213 | $146.0B | 0.64% | |
| 16 | APLSApellis Pharmaceuticals, Inc. | 2,271,917 | $143.6B | 0.63% | |
| 17 | HRTXHeron Therapeutics, Inc. | 8,131,678 | $126.2B | 0.55% | |
| 18 | AMRNAmarin Corporation plc | 26,453,422 | $115.9B | 0.51% | |
| 19 | GBTUSDGlobal Blood Therapeutics, Inc. | 3,217,441 | $112.7B | 0.49% | |
| 20 | PACBPacific Biosciences of California, Inc. | 3,201,972 | $112.0B | 0.49% | |
| 21 | IMCRImmunocore Holdings plc | 2,520,730 | $98.4B | 0.43% | |
| 22 | KYMRKymera Therapeutics, Inc. | 1,959,211 | $95.0B | 0.42% | |
| 23 | VSTMVerastem, Inc. | 21,491,630 | $87.5B | 0.38% | |
| 24 | VERVVerve Therapeutics, Inc. | 1,416,530 | $85.3B | 0.37% | |
| 25 | —Talis Biomedical Corporation | 7,574,835 | $83.5B | 0.37% | |
| 26 | CERSCerus Corporation | 13,713,195 | $81.0B | 0.36% | |
| 27 | —DBV Technologies S.A. | 14,614,264 | $79.8B | 0.35% | |
| 28 | RYTMRhythm Pharmaceuticals, Inc. | 3,863,239 | $75.6B | 0.33% | |
| 29 | TILInstil Bio, Inc. | 3,893,700 | $75.2B | 0.33% | |
| 30 | LEGNLegend Biotech Corporation | 1,664,534 | $68.3B | 0.30% | |
| 31 | NBIXNeurocrine Biosciences, Inc. | 676,975 | $65.9B | 0.29% | |
| 32 | NRIXNurix Therapeutics, Inc. | 2,454,082 | $65.1B | 0.29% | |
| 33 | IM8NInsmed Incorporated | 2,156,001 | $61.4B | 0.27% | |
| 34 | ALLKGUSDAllakos Inc. | 703,050 | $60.0B | 0.26% | |
| 35 | —Zymeworks Inc. | 1,708,472 | $59.3B | 0.26% | |
| 36 | HZNPHorizon Therapeutics Public Ltd Co | 599,110 | $56.1B | 0.25% | |
| 37 | —Forma Therapeutics Holdings, Inc. | 2,024,876 | $50.4B | 0.22% | |
| 38 | IMTXImmatics N.V. | 4,282,938 | $49.7B | 0.22% | |
| 39 | INSM 0.75 06/01/28Insmed Incorporated | 40,000,000 | $44.1B | 0.19% | |
| 40 | MRUSMerus N.V. | 2,037,469 | $42.9B | 0.19% | |
| 41 | RAREUltragenyx Pharmaceutical Inc. | 444,444 | $42.4B | 0.19% | |
| 42 | ADAPYAdaptimmune Therapeutics plc | 9,830,877 | $41.9B | 0.18% | |
| 43 | KRYSKrystal Biotech, Inc. | 607,735 | $41.3B | 0.18% | |
| 44 | KNSAKiniksa Pharmaceuticals, Ltd. | 2,799,577 | $39.0B | 0.17% | |
| 45 | SRPT 1.5 11/15/24Sarepta Therapeutics, Inc. | 29,174,000 | $38.5B | 0.17% | |
| 46 | FLGTFulgent Genetics, Inc. | 401,016 | $37.0B | 0.16% | |
| 47 | AXSMAxsome Therapeutics, Inc. | 539,057 | $36.4B | 0.16% | |
| 48 | —Neoleukin Therapeutics, Inc. | 3,821,740 | $35.3B | 0.15% | |
| 49 | BCABBioAtla, Inc. | 825,000 | $35.0B | 0.15% | |
| 50 | ADCTADC Therapeutics SA | 1,418,107 | $34.5B | 0.15% | |
| 51 | ALGSAligos Therapeutics, Inc. | 1,610,000 | $32.8B | 0.14% | |
| 52 | AVTEAerovate Therapeutics, Inc. | 1,428,571 | $32.6B | 0.14% | |
| 53 | RETAEURReata Pharmaceuticals, Inc. | 223,976 | $31.7B | 0.14% | |
| 54 | NVV1Novavax, Inc. | 143,756 | $30.5B | 0.13% | |
| 55 | ALKSAlkermes plc | 1,228,170 | $30.1B | 0.13% | |
| 56 | BCELAtreca, Inc. | 3,532,760 | $30.1B | 0.13% | |
| 57 | DSGNDesign Therapeutics, Inc. | 1,436,636 | $28.6B | 0.13% | |
| 58 | APLS 3.5 09/15/26Apellis Pharmaceuticals, Inc. | 15,000,000 | $27.8B | 0.12% | |
| 59 | TCDA 3.5 05/15/27Tricida, Inc. | 75,000,000 | $27.3B | 0.12% | |
| 60 | OPTEYOpthea Limited | 3,412,062 | $27.1B | 0.12% | |
| 61 | 698Achilles Therapeutics plc | 2,591,366 | $25.4B | 0.11% | |
| 62 | AGLEUSDAeglea BioTherapeutics, Inc. | 3,410,106 | $23.7B | 0.10% | |
| 63 | PTGXProtagonist Therapeutics, Inc. | 455,276 | $20.4B | 0.09% | |
| 64 | CYTCyteir Therapeutics, Inc. | 812,640 | $17.4B | 0.08% | |
| 65 | CRNXCrinetics Pharmaceuticals, Inc. | 920,656 | $17.4B | 0.08% | |
| 66 | OTICEUROtonomy, Inc. | 7,222,474 | $16.1B | 0.07% | |
| 67 | BMRN 0.599 08/01/24BioMarin Pharmaceutical Inc. | 15,000,000 | $15.6B | 0.07% | |
| 68 | 290AChinook Therapeutics, Inc. | 1,080,393 | $15.3B | 0.07% | |
| 69 | AUPHAurinia Pharmaceuticals Inc. | 1,119,962 | $14.5B | 0.06% | |
| 70 | BDQMAlbireo Pharma, Inc. | 412,466 | $14.5B | 0.06% | |
| 71 | XENEXenon Pharmaceuticals Inc. | 751,639 | $14.0B | 0.06% | |
| 72 | —Invitae Corporation | 10,300,000 | $13.9B | 0.06% | |
| 73 | MIRMMirum Pharmaceuticals, Inc. | 647,313 | $11.2B | 0.05% | |
| 74 | ANABAnaptysBio, Inc. | 427,179 | $11.1B | 0.05% | |
| 75 | EWTXEdgewise Therapeutics, Inc. | 500,000 | $10.7B | 0.05% | |
| 76 | ALTAltimmune, Inc. | 1,072,038 | $10.6B | 0.05% | |
| 77 | CBAYUSDCymabay Therapeutics, Inc. | 2,170,464 | $9.5B | 0.04% | |
| 78 | —Genetron Holdings Limited | 455,306 | $9.2B | 0.04% | |
| 79 | CNTACentessa Pharmaceuticals plc | 400,000 | $8.9B | 0.04% | |
| 80 | OPHTEURIVERIC bio, Inc. | 1,406,037 | $8.9B | 0.04% | |
| 81 | —Athira Pharma, Inc. | 806,367 | $8.3B | 0.04% | |
| 82 | ASMBAssembly Biosciences, Inc. | 2,108,621 | $8.2B | 0.04% | |
| 83 | KRTXKaruna Therapeutics, Inc. | 69,966 | $8.0B | 0.04% | |
| 84 | MREOMereo BioPharma Group plc | 2,459,399 | $7.8B | 0.03% | |
| 85 | SPRYSilverback Therapeutics, Inc. | 238,095 | $7.4B | 0.03% | |
| 86 | —bluebird bio, Inc. | 226,988 | $7.3B | 0.03% | |
| 87 | RVMDRevolution Medicines, Inc. | 222,222 | $7.1B | 0.03% | |
| 88 | DNLIDenali Therapeutics Inc. | 88,738 | $7.0B | 0.03% | |
| 89 | —Chiasma, Inc. | 1,420,740 | $6.7B | 0.03% | |
| 90 | HOOKGBPHOOKIPA Pharma Inc. | 700,481 | $6.4B | 0.03% | |
| 91 | BNRBurning Rock Biotech Limited | 209,131 | $6.2B | 0.03% | |
| 92 | REPLReplimune Group, Inc. | 153,512 | $5.9B | 0.03% | |
| 93 | NGMUSDNGM Biopharmaceuticals, Inc. | 291,801 | $5.8B | 0.03% | |
| 94 | CABACabaletta Bio, Inc. | 636,363 | $5.5B | 0.02% | |
| 95 | MGNXMacroGenics, Inc. | 200,679 | $5.4B | 0.02% | |
| 96 | ORTXUSDOrchard Therapeutics plc | 1,192,003 | $5.2B | 0.02% | |
| 97 | ALECAlector, Inc. | 239,228 | $5.0B | 0.02% | |
| 98 | —NexImmune, Inc. | 294,117 | $4.8B | 0.02% | |
| 99 | BMEABiomea Fusion, Inc. | 294,117 | $4.6B | 0.02% | |
| 100 | —Gamida Cell Ltd. | 610,626 | $3.9B | 0.02% |
Page 1 of 2Next